drugset / Trial / NCT02155829
Safety Study of Riluzole to Treat Post-traumatic Stress Disorder (PTSD)
Phase 1/2
Completed
75 enrolled
Uniformed Services University of the Health Sciences
U.S. Army Medical Research and Development Command · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether Riluzole is effective in the augmentation treatment of post-traumatic stress disorder (PTSD) that is experienced by Active Duty military service members and Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) veterans who have not had symptom reduction after one or more kinds of medications or therapies.
Timeline
- Start
- 2013-07
- Primary completion
- 2017-10-30
- Completion
- 2017-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Riluzole | Small molecule | 200 mg | Oral |